Notes Payable and Note payable-other (Details Narrative) - USD ($)					1 Months Ended			3 Months Ended					6 Months Ended
	Jul. 26, 2023	Dec. 05, 2022	Jan. 31, 2015	Sep. 30, 2014	Feb. 06, 2024	Nov. 30, 2021	Jul. 31, 2020	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Aug. 19, 2021	Nov. 30, 2016	Jun. 30, 2016	Mar. 03, 2016	Mar. 01, 2016	Jun. 30, 2015
Debt Instrument [Line Items]
Credit line interest rate													6.24%
Principle amount repaid															$ 300,000
Repayment of debt						$ 100,000
Short term notes payable								$ 100,000		$ 100,000			$ 100,000
Interest and accrued interest liability								3,000			$ 3,000		6,000	$ 6,000
Accrued interest payable								94,677		88,677			94,677
Notes payable - other								50,000		50,000			50,000
Settlement agreement terms					On February 6, 2024, the Company entered into an amendment to Settlement Agreement related to above two litigations where within two days of the signing of this Amendment, WHSI shall make total payments in the amount of twenty thousand dollars ($20,000) and a ten thousand payment ($10,000) made on or before April 5th, 2024, to “GRQ” pursuant to the payment instructions provided by Mr. Honig. This $20,000 payment shall be credited to the Second Nevada Settlement Payment for the Benza Pharma LLC note as that term is defined in the Settlement Agreement. All outstanding principal and accrued interest shall be due on April 15th, 2024 (the “Extended Due Date”).
Convertible notes balance outstanding								518,750		673,750			518,750
Proceeds from convertible debt													0	240,000
Convertible notes payable - Leonite								295,122		246,148			295,122
Stock issued new, value									$ 114,000		25,000	$ 604,500
Common stock to be issued, value								216,189		604,335			216,189
Amortization of debt issuance costs													23,974	3,480
Amortization of original issue discount													25,000	3,629
Gain on debt extinguishment								239,834			0		637,334	0
Line of credit, outstanding								0		397,500			0
Medi Pendant [Member]
Debt Instrument [Line Items]
Credit line interest rate			6.50%
Accrued Interest																	$ 25,653			$ 8,436
Line of credit borrowing capacity				$ 300,000
Maturity date				Sep. 30, 2017
Line of credit current borrowing capacity			$ 500,000
Stock issued for services, shares			200,000
Gain on debt extinguishment													397,500
Line of credit, outstanding								0		397,500			0
BENZA and D2CF [Member]
Debt Instrument [Line Items]
Debt face amount																			$ 612,500
Convertible notes balance outstanding								518,750		673,750			518,750
B2CF [Member]
Debt Instrument [Line Items]
Convertible notes																			$ 13,750
BENZA [Member]
Debt Instrument [Line Items]
Convertible notes																		$ 660,000
Repayment of convertible notes	$ 145,000
GQR Consultant [Member]
Debt Instrument [Line Items]
Repayment of convertible notes	$ 10,000
Leonite Convertible Note [Member]
Debt Instrument [Line Items]
Interest expense								8,789					17,578
Proceeds from convertible debt		$ 250,000
Original issue discount		$ 62,500
Maturity date		Mar. 05, 2024
Periodic payment													34,722
Legal fees													10,000
Debt issuance costs								59,936					$ 59,936
Amortization of debt issuance costs								11,987
Amortization of original issue discount								12,500
Debt interest rate terms													The Leonite Convertible Note bears annual interest at the greater of 10% or the Prime Rate plus three percent (3%).
Leonite Convertible Note [Member] | Commitment Shares [Member]
Debt Instrument [Line Items]
Stock issued new, shares													15,000,000
Stock issued new, value													$ 78,000
Common stock to be issued, value								28,064					28,064
Leonite Payable [Member]
Debt Instrument [Line Items]
Convertible notes payable - Leonite								295,122		246,148			295,122
Susquehanna [Member]
Debt Instrument [Line Items]
Notes and Loans Payable								0		0			0
Party Related To A Previous C E O [Member]
Debt Instrument [Line Items]
Accrued Interest								14,282		13,282			14,282
Notes payable - other																$ 50,000
Debt stated interest rate																4.00%
Interest expense								500			500		1,000	1,000
MCA Cure [Member]
Debt Instrument [Line Items]
Prepaid fund								0		0			0
On Deck [Member]
Debt Instrument [Line Items]
Prepaid fund								139,569		139,569			139,569
Regulation A Filing [Member] | Two Unaffiliated Investors [Member]
Debt Instrument [Line Items]
Accepted stock payment										140,000			140,000
Interest expense								2,700			$ 2,700		5,400	$ 5,400
Accrued Interest								$ 28,507		$ 23,107			$ 28,507
COHEN [Member]
Debt Instrument [Line Items]
Short term bridge loan							$ 500,000
Interest rate							12.00%
Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate During Period													9.24%
Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate During Period													10.90%